Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PercuSurge raises $15 million in financing:

This article was originally published in Clinica

Executive Summary

PercuSurge has completed a private placement, raising $15 million. The Sunnyvale, California-based company plans to use the fresh funds in efforts to gain FDA approval for its GuardWire Plus, for use in diseased saphenous vein grafts. The system helps contain and remove excess particles and blood clots that often get dislodged during the treatment of atherosclerosis. Investor Growth Capital led the financing. Its managing director, Stephen Campe, said: "We performed an extensive amount of due diligence during our evaluation of this investment and see PercuSurge as a clear emerging leader in this field."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel